The Business of Diabetes

The diabetes explosion has translated to big business for many drug and device manufacturers. Wall Street analysts now estimate that the market for diabetes devices and drugs will top $30 billion by the end of the decade. dLife's newest contributor, David Kliff, offers a unique perspective on investing in diabetes.

Comments